| 摘要: |
| 目的探讨玻璃体腔注射雷珠单抗联合FP-7Ahmed青光眼引流阀植入术治疗新生血管性青光眼（NVG）的疗效。方法选取采用玻璃体腔注射雷珠单抗联合FP-7Ahmed青光眼引流阀植入术治疗的NVG患者36例（38眼）作为观察组，选取同期仅给予FP-7Ahmed青光眼引流阀植入术治疗的NVG患者34例（35眼）作为对照组。比较两组患者虹膜表面新生血管消退情况、眼压、视力及并发症发生率。结果观察组35眼（92.1%）虹膜表面新生血管完全消退，3眼（7.9%）残存少许新生血管，对照组所有患者虹膜表面仍可见新生血管。观察组术后1d、7d、1个月、3个月和6个月眼压均显著低于对照组（均P＜0.05）。观察组术后6个月视力较对照组显著改善（P＜0.05）。两组患者角膜水肿、前房渗出、浅前房和低眼压发生率比较差异均无统计学意义（均P＞0.05）。观察组前房出血和引流管堵塞发生率均显著低于对照组（均P＜0.05）。结论玻璃体腔注射雷珠单抗联合FP-7Ahmed青光眼引流阀植入术治疗NVG安全有效。 |
| 关键词: 新生血管性青光眼 雷珠单抗 FP-7Ahmed 青光眼引流阀 |
| DOI：10.12056/j.issn.1006-2785.2018.40.12.2017-1970 |
| 分类号: |
| 基金项目: |
|
| Efficacy of ranibizumab combined with FP-7Ahmed valve implantation for neovascular glaucoma |
|
|
| Abstract: |
| Objective To evaluate the efficacy of ranibizumab combined with FP-7Ahmed valve implantation for neovascular glaucoma (NVG). Methods Seventy patients (73 eyes) with NVG were assigned in two groups: 34 cases (35 eyes) were treated with FP-7Ahmed valve implantation(control group) and 36 cases(38 eyes) were treated with FP-7Ahmed valve implantation and ranibizumab (study group). The neovascular vanishment, intraocular pressure, vision and complications were compared between two groups. Results In study group, the new vessels completely vanished in 35 eyes (92.1%) and few new vessels remained in 3 eyes (7.9%), while no case had completed neovascular vanishment in control group. At 1d, 7d, 1 month, 3 month and 6 month after treatment, the intraocular pressure in study group was significantly lower than that in control group(all
P＜0.05). At 6 month after treatment, the vision of study group was significantly better than that of control group (P＜0.05). There
were no significant differences in incidence of anterior chamber exudation, low intraocular pressure and corneal edema between two groups(all P ＞0.05). Compared with control group, the incidence of bleeding of anterior chamber and drainage tube blocking in study group was significantly lower less than that in control group(both P＜0.05). Conclusion Ranibizumab combined with FP-7Ahmed valve implantation is safe and effective in treatment of neovascular glaucoma. |
| Key words: Neovascular glaucoma Ranibizumab FP-7Ahmed valve implantation |
